Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Cash from Discontinued Operations (2016 - 2017)

Historic Cash from Discontinued Operations for Lisata Therapeutics (LSTA) over the last 4 years, with Q4 2017 value amounting to $69.0.

  • Lisata Therapeutics' Cash from Discontinued Operations fell 9999.65% to $69.0 in Q4 2017 from the same period last year, while for Sep 2018 it was $69.0, marking a year-over-year decrease of 9999.47%. This contributed to the annual value of -$638000.0 for FY2017, which is 11399.84% down from last year.
  • Per Lisata Therapeutics' latest filing, its Cash from Discontinued Operations stood at $69.0 for Q4 2017, which was down 9999.65% from $4.9 million recorded in Q2 2017.
  • In the past 5 years, Lisata Therapeutics' Cash from Discontinued Operations ranged from a high of $4.9 million in Q2 2017 and a low of -$5.5 million during Q1 2017